Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CBR3 Protein, N-His

Catalog #:   YHB32101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O75828
Protein length: Met1-Trp277
Overview

Catalog No.

YHB32101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Trp277

Predicted molecular weight

33.16 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O75828

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Carbonyl reductase [NADPH] 3, Short chain dehydrogenase/reductase family 21C member 2, NADPH-dependent carbonyl reductase 3, CBR3

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CBR3 protein
References

Drugs Metabolism-Related Genes Variants Impact on Anthracycline-Based Chemotherapy Induced Subclinical Cardiotoxicity in Breast Cancer Patients., PMID:40362292

The impact of CBR3 (rs1056892) and ABCC1 (rs45511401) genetic polymorphisms on doxorubicin-induced cardiotoxicity and the potential role of brain natriuretic peptide as an early cardiac biomarker in breast cancer patients., PMID:40207889

Influence of Polymorphisms in Pharmacokinetics-Related Genes on the Areas Under the Plasma Concentration-Time Curves of Doxorubicin and Doxorubicinol in Patients with Diffuse Large B-Cell Lymphoma Receiving CHOP Therapy., PMID:40186087

RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3/CBR3-AS1/miR-409-3p/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer., PMID:39962467

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer., PMID:39548148

Integrated machine learning and bioinformatic analysis of mitochondrial-related signature in chronic rhinosinusitis with nasal polyps., PMID:39328210

Multi-omics characterization of type 2 diabetes mellitus-induced gastroenteropathy in the db/db mouse model., PMID:39211388

Regulatory role of PDK1 via integrated gene analysis of mitochondria-immune response in periodontitis., PMID:38657876

Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine., PMID:37722844

Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population., PMID:37642051

PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer., PMID:36598702

LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway., PMID:36591804

Identification of Small Airway Epithelium-Related Hub Genes in Chronic Obstructive Pulmonary Disease., PMID:36475041

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism., PMID:36467030

Identification of expression of CCND1-related lncRNAs in breast cancer., PMID:35803208

CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4., PMID:35655916

Bioinformatics detection of modulators controlling splicing factor-dependent intron retention in the human brain., PMID:35391504

Long Non-coding RNA CBR3 Antisense RNA 1 is Downregulated in Colorectal Cancer and Inhibits miR-29a-Mediated Cell Migration and Invasion., PMID:35107754

Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 /miR-409-3p/SOD1 axis., PMID:34801596

Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker., PMID:34582659

Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia., PMID:34096893

Environmental and Genetic Factors in the Pathogenesis of COPD in the Road-Working Population., PMID:34012494

Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling., PMID:34001990

The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition., PMID:33871046

The interaction between miRNAs/lncRNAs and Notch pathway in human disorders., PMID:33743335

LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway., PMID:33494806

Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer., PMID:33445170

Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers., PMID:33036882

Long noncoding RNA CBR3 antisense RNA 1 promotes the aggressive phenotypes of non‑small‑cell lung cancer by sponging microRNA‑509‑3p and competitively upregulating HDAC9 expression., PMID:32945466

Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified., PMID:31955137

Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function., PMID:31779149

Identification of gene and microRNA changes in response to smoking in human airway epithelium by bioinformatics analyses., PMID:31568004

Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response., PMID:31377417

Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer., PMID:31056713

Carbonyl reductase sniffer from the model organism daphnia: Cloning, substrate determination and inhibitory sensitivity., PMID:30991043

Effects of JUN and NFE2L2 knockdown on oxidative status and NFE2L2/AP-1 targets expression in HeLa cells in basal conditions and upon sub-lethal hydrogen peroxide treatment., PMID:30515697

NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP., PMID:30125887

PlncRNA-1 is overexpressed in retinoblastoma and regulates retinoblastoma cell proliferation and motility through modulating CBR3., PMID:30096220

Carbonyl reductases from Daphnia are regulated by redox cycling compounds., PMID:29893480

Screening of potential biomarkers in uterine leiomyomas disease via gene expression profiling analysis., PMID:29568968

LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma., PMID:29554595

Low-Dose Anthracycline and Risk of Heart Failure in a Pharmacokinetic Model of Human Myocardium Exposure: Analog Specificity and Role of Secondary Alcohol Metabolites., PMID:29222131

Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin., PMID:29117945

Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial., PMID:28763429

The role of carbonyl reductase 1 in drug discovery and development., PMID:28712324

Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events., PMID:28679691

Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs., PMID:28450226

Native Mass Spectrometry of Recombinant Proteins from Crude Cell Lysates., PMID:28345863

Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia., PMID:27738808

Coregulation of tandem duplicate genes slows evolution of subfunctionalization in mammals., PMID:27199432

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CBR3 Protein, N-His [YHB32101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only